Pharmaceutical Intermediates Market to Incur High Value Growth at 4.4 % CAGR During 2019 - 2029

1
Pharmaceutical Intermediates Market to Incur High
Value Growth at 4.4 CAGR During 2019 - 2029

• March 2020

Report Id REP-GB-4515 Published On 26 April,
2019 Category Healthcare, Pharmaceuticals
Medical Devices
2
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage

• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research

• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment

• Chemicals Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email hari.t_at_futuremarketinsights.co
m
3
Research Methodology (1/2)

• Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)

• Identifying key opinion leaders
• Questionnaire design
• In-depth interviews
• Coverage across value chain

• Key industry experts
• Channel study
• Developments
• Market dynamics
• Products
• Conclusions

SOLUTION

• Market participants
• Key strengths
• Product portfolio
• Mapping as per value chain
• Key focus segments

Primary Research
Secondary Research
Paid Publications

• Linkedin
• Zoominfo
• Salesforce
• Avention

• Factiva
• GBI
• Genios
• Meltwater

• Company websites
• Company annual reports
• White papers
• Financial reports

includes sources of databases
4
Pharmaceutical Intermediates Market

• Global sales of pharmaceutical intermediates
  closed in on US 26 billion 2018, which is likely
  to see modest Y-o-Y growth in 2019, by an
  estimated 3.6 rate. More than 70 of
  the pharmaceutical intermediates consumed, were
  generic. A moderate demand growth outlook has
  been projected for branded pharmaceutical
  intermediates.
• Prominently driven by high sales of chiral
  intermediates, bulk drug intermediates will
  continue to account for over 3/5th of overall
  sales, followed by chemical intermediates. The
  report highlights pivotal role of CROs (contract
  research organizations) and CMOs (contract
  manufacturing organizations) in shaping the
  pharmaceutical intermediates market, as they
  collectively contribute more than 60 to the
  market value. Pharma and biotech companies are
  also likely to develop as key end users of
  pharmaceutical intermediates in the near future.
• Application in Analgesics Account for a Third of
  Global Revenue
• Increasing prevalence of the chronic diseases,
  coupled with the improved rate of early
  diagnosis, is heavily contributing to the
  towering drug demand. The report opines that
  prevalence rate of CVDs (cardiovascular diseases)
  and diabetes will particularly bolster
  pharmaceutical intermediates consumption. Over
  1/3rd of the pharmaceutical intermediates market
  revenues is accounted by application in
  analgesics, followed by cardiovascular drugs and
  oral antidiabetic drugs, as reported by the
  study.
• Moreover, the increasing rate of seeking
  treatment is also likely to boost the demand for
  drugs. According to the report, global pandemics,
  such as H1N1, Ebola, and others are also
  accounting for fostering drug demand thereby
  pushing consumption of a wide range of APIs and
  pharmaceutical intermediates.

5
Pharmaceutical Intermediates Market

• Manufacturing Companies to Strategize on
  Increasing Drug Approvals
• A couple of years ago, the Center for drug
  evaluation and research (CDER) approved more than
  45 novel drugs, compared to 22 in 2016. The
  average novel drug approval each year, is around
  31 and, and thus FMIs analysis finds that the
  year 2017 witnessed a significant rise in the
  number of drug approvals. With the number of drug
  approvals on a constant rise, it is highly likely
  that the demand for pharmaceutical raw materials
  such as pharmaceutical intermediates and APIs
  will also witness gains in the years to come.
• To cater to billowing demand in drug
  formulations, a number of players prominently
  active in the global pharmaceutical intermediates
  landscape are maintaining focus on expanding
  production capacity. Merck KGaA, for an instance,
  has announced production capacity expansion in
  Aubonne, Switzerland. The new production facility
  is supposed to be fully functional by the end of
  2023, as reported. The production capacity will
  be enhanced by over 50 of the existing.
• Pharmaceutical intermediates manufacturers
  seeking cGMP (Current Good Manufacturing Practice
  regulations) approval from various western
  regulatory bodies. Key manufacturers of
  pharmaceutical intermediates, particularly those
  based in the East and South Asian regions, are
  focused on their efforts in gaining FDA or EMA
  (European Medicine Agency) regulatory approvals
  for their manufacturing plants.
• FMIs research marks that the production costs
  associated with pharmaceutical intermediates,
  APIs, and final drug formulations is around
  50-60 less when based in emerging Asian markets,
  compared to that in North America and Europe.
  This cost benefit according to the report will
  continue to attract foreign investments from
  pharmaceutical and biopharmaceutical companies
  based in overseas. On the other side, leading
  exporters of pharmaceutical intermediates are
  focusing on blending the lower production costs
  and high quality.

6
Pharmaceutical Intermediates Market

• The report tracks some of the key companies
  operating in the Pharmaceutical Intermediates
  market, including Chiracon GmbH, Aceto
  Corporation, Midas Pharma GmbH, BASF SE, Codexis,
  Inc., A.R. Life Sciences Private Limited, Dishman
  Group, ZCL Chemicals Ltd., Pfizer, Inc., Arkema
  Inc and Cambrex Corporation among others.
• Source of Press-Release  https//www.globenewswir
  e.com/news-release/2019/04/29/1811232/0/en/Pharmac
  eutical-Intermediates-Market-Estimated-to-Expand-a
  t-a-Robust-CAGR-of-4-4-CAGR-over-2029-Future-Marke
  t-Insights.html
• About Us
• Future Market Insights (FMI) is a leading market
  intelligence and consulting firm. We deliver
  syndicated research reports, custom research
  reports and consulting services which are
  personalized in nature. FMI delivers a complete
  packaged solution, which combines current market
  intelligence, statistical anecdotes, technology
  inputs, valuable growth insights and an aerial
  view of the competitive framework and future
  market trends.
• Contact Us
• Mr. Abhishek BudholiyaFuture Market Insights616
  Corporate Way, Suite 2-9018,Valley Cottage, NY
  10989,United StatesT 1-347-918-3531F
  1-845-579-5705T (UK) 44 (0) 20 7692
  8790Sales sales_at_futuremarketinsights.com

7
To know more about us, please visit our website
www.futuremarketinsights.com For sales queries
or new topics email us on sales_at_futuremarketinsi
ghts.com For media queries, contact the press
office at press_at_futuremarketinsights.com For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email hari.t_at_futuremarketinsights.com
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)